Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Gavi Signs $5M Advance Deal for Merck's Ebola Vaccine

January 20, 2016 10:36 am | by Ryan Bushey, Associate Editor | News | Comments

The injection was shown to be highly effective in clinical trials done over the summer. Read more...

TOPICS:

Research Discovers Potential New Therapeutic Target for ALS

January 20, 2016 10:00 am | by Louisiana State University | News | Comments

J. Gavin Daigle, a PhD candidate at the LSU Health New Orleans School of Graduate Studies, is the first author of a paper whose findings reveal another piece of the Amyotrophic Lateral Sclerosis (ALS) puzzle. Read more...

TOPICS:

Zafgen Touts Positive Study Results for Obesity Drug

January 20, 2016 9:22 am | by Ryan Bushey, Associate Editor | News | Comments

Two patients had died during phase 3 clinical trials. Read more...

TOPICS:
Advertisement

EU Approves Biogen's RA Biosimilar

January 20, 2016 8:21 am | News | Comments

The EC approval was based on a robust preclinical and clinical data package submitted to the European Medicines Agency by Samsung Bioepis. Read more...

TOPICS:

Biden Discusses More Details on Cancer Moonshot Initiative

January 20, 2016 8:21 am | by Ryan Bushey, Associate Editor | News | Comments

The Vice President elaborated on the project as part of a panel at the 2016 World Economic Forum in Davos, Switzerland. Read more...

TOPICS:

Brazil Launches Vaccine Fund to Fight Zika Virus

January 20, 2016 8:20 am | by Ryan Bushey, Associate Editor | News | Comments

The country is known as a hot bed for diseases delivered by mosquitoes, but the current economic recession may have played a role in the surge of Zika cases. Read more...

TOPICS:

B12 Deficiency a Concern for Long-Term Care

January 20, 2016 7:45 am | by University of Waterloo | News | Comments

A high proportion of older adults entering long-term care homes in Ontario are B12 deficient. Read more...

TOPICS:

Two Indian States Halt Sales of Roche's Avastin Drug

January 20, 2016 7:30 am | by Aditya Kalra, Reuters | News | Comments

Two Indian states have put sales of Swiss drugmaker Roche's blockbuster drug Avastin on hold. Read more...

TOPICS:
Advertisement

Omega-3 Levels Affect Whether B Vitamins Can Slow Brain's Decline

January 20, 2016 7:15 am | by University of Oxford | News | Comments

An international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect. Read more...

TOPICS:

Parkinson's Disease Treatment Pipeline Shows Promise for Patients, Investors

January 20, 2016 7:00 am | by Angel Wong, Senior Analyst, GBI Research | News | Comments

The Parkinson’s disease treatment pipeline presents a distinctly more promising landscape than the current market. Read more...

TOPICS:

NIH Genome Sequencing Program Targets the Genomic Bases of Common, Rare Disease

January 19, 2016 11:44 am | by National Institutes of Health (NIH) | News | Comments

The National Institutes of Health will fund a set of genome sequencing and analysis centers whose research will focus on understanding the genomic bases of common and rare human diseases. Read more...

TOPICS:

Study Quantifies Faulty Gene's Role in Ovarian Cancer Risk

January 19, 2016 11:36 am | News | Comments

Women who carry an inherited fault in the BRIP1 gene are three times more likely to develop ovarian cancer than those without it, researchers said Tuesday. The gene variant had already been linked to cancer of the ovaries, but the size of the additional risk has now been quantified in a study in the Journal of the National Cancer Institute. Read more...

TOPICS:

Scientists Take Steps to Make Weak TB Drugs Strong Again

January 19, 2016 11:12 am | by Johns Hopkins | News | Comments

Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others. Read more...

TOPICS:

J&J to Cut 3,000 Jobs in Struggling Medical Device Division

January 19, 2016 10:49 am | by Reuters | News | Comments

Johnson & Johnson said on Tuesday it would cut about 3,000 jobs within its medical devices unit over the next two years, or about 4 to 6 percent of the struggling division's global workforce, to generate annual cost savings of up to $1 billion and focus on more innovative products. Read more...

TOPICS:

Accelerating Drug Discovery Through Data Analysis

January 19, 2016 10:00 am | by Ryan Bushey, Associate Editor | Articles | Comments

Clinical research can be a risky and laborious process, but this startup could solve that problem. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading